Target identification by multi-omics and target validation in patient-derived organoids in cancer
-
The Innovation & Entrepreneurship department will host a hybrid lecture from Eberhard Krauss, Group Leader - In vitro Biology (Oncology) at Evotec.
The company lecture will delve into how new targets are identified based on a multi omics approach and which parameters determine target selection.
In a second part of the lecture Eberhard will delve into target validation using organoid models for oncology targets.
Please register to attend the lecture in person in BIMSB R 0.61 Elsa Neumann or to receive the Zoom link. We invite you to also indicate your main research areas of interest and potential questions for the speaker and get ready to engage in interactive discussions.
Venue
MDC-BIMSB
Hannoversche Straße 28
10115 Berlin
Germany
Time
-
Program
Speaker: Eberhard Krauss, Group leader screening and target validation, Evotec